<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US6333045 - Gatifloxacin or its salt and disodium EDTA to prevent coloration; eye, ear ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Gatifloxacin or its salt and disodium EDTA to prevent coloration; eye, ear or nose drops"><meta name="DC.contributor" content="Shinichi Yasueda" scheme="inventor"><meta name="DC.contributor" content="Katsuhiro Inada" scheme="inventor"><meta name="DC.contributor" content="Senju Pharmaceutical Co., Ltd." scheme="assignee"><meta name="DC.contributor" content="Kyorin Pharmaceutical Co., Ltd." scheme="assignee"><meta name="DC.date" content="1999-8-20" scheme="dateSubmitted"><meta name="DC.description" content="There is provided an aqueous liquid pharmaceutical composition which comprises Gatifloxacin (chemical nomenclature: (±)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinoline carboxylic acid) or its salt and disodium edetate. Further, there are provided a method for raising corneal permeability of Gatifloxacin, a method for preventing precipitation of Gatifloxacin crystals, and a method for preventing coloration of Gatifloxacin by incorporating disodium edetate into an aqueous liquid preparation containing Gatifloxacin or its salt."><meta name="DC.date" content="2001-12-25" scheme="issued"><meta name="DC.relation" content="US:4528287" scheme="references"><meta name="DC.relation" content="US:4780465" scheme="references"><meta name="DC.relation" content="US:4980470" scheme="references"><meta name="DC.relation" content="US:5043450" scheme="references"><meta name="citation_reference" content="Grass George M., et al., &quot;Effects of Calcium Chelating Agents on Corneal Permeability&quot;, Investigative Ophthalmology &amp; Visual Science/Jan. 1985, vol. 26, pp. 110-113."><meta name="citation_reference" content="Grass George M., et al., &quot;Mechanisms of Corneal Drug Penetration 1: In Vivo and In Vitro Kinetics&quot;, Journal of Pharmaceutical Sciences, Jan. 1988, vol. 77, No. 1, pp. 3-14."><meta name="citation_reference" content="Kubo Shuta et al., &quot;Enhanced Chemiluminescence Response of Polymorphonuclear Leukocytes by New Quinolone Antimicrobials&quot;, Chemotherapy, 1994, vol. 40, No. 5, pp. 333-336."><meta name="citation_reference" content="Podder, Samir K., et al. &quot;Improving the Safety of Topically Applied Timolol in the Pigmented Rabbit Through Manipulation of Formulation Composition&quot;, Exp. Eye Res. (1992), 54, pp. 747-757."><meta name="citation_reference" content="Sasaki, Hitoshi et al., &quot;Different Effects of Absorption Promoters on Corneal and Conjunctival Penetration of Ophthalmic Beta-Blockers&quot;, Pharmaceutical Research, 1995, vol. 12, No. 8, pp. 1146-1150."><meta name="citation_reference" content="Tanaka, Masatoshi et al., &quot;Emergence of In Vitro Resistance to Fluoroquinolones in Neisseria gonorrhoeae Isolated in Japan&quot;, Antimicrobial Agents and Chemotherapy, 1995, vol. 39, No. 10, pp. 2367-2370."><meta name="citation_patent_number" content="US:6333045"><meta name="citation_patent_application_number" content="US:09/529,882"><link rel="canonical" href="http://www.google.com/patents/US6333045"/><meta property="og:url" content="http://www.google.com/patents/US6333045"/><meta name="title" content="Patent US6333045 - Gatifloxacin or its salt and disodium EDTA to prevent coloration; eye, ear or nose drops"/><meta name="description" content="There is provided an aqueous liquid pharmaceutical composition which comprises Gatifloxacin (chemical nomenclature: (±)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinoline carboxylic acid) or its salt and disodium edetate. Further, there are provided a method for raising corneal permeability of Gatifloxacin, a method for preventing precipitation of Gatifloxacin crystals, and a method for preventing coloration of Gatifloxacin by incorporating disodium edetate into an aqueous liquid preparation containing Gatifloxacin or its salt."/><meta property="og:title" content="Patent US6333045 - Gatifloxacin or its salt and disodium EDTA to prevent coloration; eye, ear or nose drops"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("boXtU6CEH9SysQTD_4CQAg"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("GBR"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("boXtU6CEH9SysQTD_4CQAg"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("GBR"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us6333045?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US6333045"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=8ENYBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS6333045&amp;usg=AFQjCNGiMDMh6utSa5U7jmUKubEr0tcF5Q" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US6333045.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US6333045.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US6333045" style="display:none"><span itemprop="description">There is provided an aqueous liquid pharmaceutical composition which comprises Gatifloxacin (chemical nomenclature: (±)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinoline carboxylic acid) or its salt and disodium edetate. Further, there are provided a method for...</span><span itemprop="url">http://www.google.com/patents/US6333045?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US6333045 - Gatifloxacin or its salt and disodium EDTA to prevent coloration; eye, ear or nose drops</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US6333045 - Gatifloxacin or its salt and disodium EDTA to prevent coloration; eye, ear or nose drops" title="Patent US6333045 - Gatifloxacin or its salt and disodium EDTA to prevent coloration; eye, ear or nose drops"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US6333045 B1</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 09/529,882</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Dec 25, 2001</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Aug 20, 1999</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Aug 21, 1998</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2307632A1">CA2307632A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2307632C">CA2307632C</a>, </span><span class="patent-bibdata-value"><a href="/patents/CN1133432C">CN1133432C</a>, </span><span class="patent-bibdata-value"><a href="/patents/CN1275081A">CN1275081A</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69932313D1">DE69932313D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69932313T2">DE69932313T2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1025846A1">EP1025846A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1025846A4">EP1025846A4</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1025846B1">EP1025846B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO2000010570A1">WO2000010570A1</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">09529882, </span><span class="patent-bibdata-value">529882, </span><span class="patent-bibdata-value">US 6333045 B1, </span><span class="patent-bibdata-value">US 6333045B1, </span><span class="patent-bibdata-value">US-B1-6333045, </span><span class="patent-bibdata-value">US6333045 B1, </span><span class="patent-bibdata-value">US6333045B1</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Shinichi+Yasueda%22">Shinichi Yasueda</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Katsuhiro+Inada%22">Katsuhiro Inada</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Senju+Pharmaceutical+Co.,+Ltd.%22">Senju Pharmaceutical Co., Ltd.</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Kyorin+Pharmaceutical+Co.,+Ltd.%22">Kyorin Pharmaceutical Co., Ltd.</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US6333045.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6333045.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6333045.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (4),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (6),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (16),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (20),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (9)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/6333045&usg=AFQjCNEy_OpoeygOAjtGvQGJsW1FMV6WbA">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D6333045&usg=AFQjCNFiO6r_3o871ykI4EWyqyXDmUPBSQ">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D6333045B1%26KC%3DB1%26FT%3DD&usg=AFQjCNGgRrxBZtSXsmEhAlRkG37Yor67oA">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT128989078" lang="EN" load-source="ifi">Gatifloxacin or its salt and disodium EDTA to prevent coloration; eye, ear or nose drops</invention-title></span><br><span class="patent-number">US 6333045 B1</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA72658762" lang="EN" load-source="patent-office"> <div class="abstract">There is provided an aqueous liquid pharmaceutical composition which comprises Gatifloxacin (chemical nomenclature: (±)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinoline carboxylic acid) or its salt and disodium edetate. Further, there are provided a method for raising corneal permeability of Gatifloxacin, a method for preventing precipitation of Gatifloxacin crystals, and a method for preventing coloration of Gatifloxacin by incorporating disodium edetate into an aqueous liquid preparation containing Gatifloxacin or its salt.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(9)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6333045-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6333045-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6333045-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6333045-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6333045-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6333045-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6333045-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6333045-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6333045-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6333045-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6333045-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6333045-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6333045-6.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6333045-6.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6333045-7.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6333045-7.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6333045-8.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6333045-8.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(11)</span></span></div><div class="patent-text"><div mxw-id="PCLM28751230" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>What is claimed is: </claim-statement> <div class="claim"> <div num="1" id="US-6333045-B1-CLM-00001" class="claim">
      <div class="claim-text">1. An aqueous liquid pharmaceutical composition which comprises Gatifloxacin or its salt and disodium edetate.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" id="US-6333045-B1-CLM-00002" class="claim">
      <div class="claim-text">2. The aqueous liquid pharmaceutical composition according to claim <b>1</b>, wherein pH of the composition is within the range of 5 to 8.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" id="US-6333045-B1-CLM-00003" class="claim">
      <div class="claim-text">3. The aqueous liquid pharmaceutical composition according to claim <b>1</b>, where the composition is in the form of eye drops.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" id="US-6333045-B1-CLM-00004" class="claim">
      <div class="claim-text">4. The aqueous liquid pharmaceutical composition according to claim <b>1</b>, where the composition is in the form of ear drops.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" id="US-6333045-B1-CLM-00005" class="claim">
      <div class="claim-text">5. The aqueous liquid pharmaceutical composition according to claim <b>1</b>, where the composition is in the form of nasal drops.</div>
    </div>
    </div> <div class="claim"> <div num="6" id="US-6333045-B1-CLM-00006" class="claim">
      <div class="claim-text">6. A method for raising corneal permeability of Gatifloxacin which comprises incorporating disodium edetate into eye drops containing Gatifloxacin or its salt.</div>
    </div>
    </div> <div class="claim"> <div num="7" id="US-6333045-B1-CLM-00007" class="claim">
      <div class="claim-text">7. A method for preventing precipitation of Gatifloxacin crystals which comprises incorporating disodium edetate into an aqueous liquid preparation containing Gatifloxacin or its salt.</div>
    </div>
    </div> <div class="claim"> <div num="8" id="US-6333045-B1-CLM-00008" class="claim">
      <div class="claim-text">8. A method for preventing coloration of Gatifloxacin which comprises incorporating disodium edetate into an aqueous liquid preparation containing Gatifloxacin or its salt.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="9" id="US-6333045-B1-CLM-00009" class="claim">
      <div class="claim-text">9. The aqueous liquid pharmaceutical composition according to claim <b>2</b>, where the composition is in the form of eye drops.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="10" id="US-6333045-B1-CLM-00010" class="claim">
      <div class="claim-text">10. The aqueous liquid pharmaceutical composition according to claim <b>2</b>, where the composition is in the form of ear drops.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="11" id="US-6333045-B1-CLM-00011" class="claim">
      <div class="claim-text">11. The aqueous liquid pharmaceutical composition according to claim <b>2</b>, where the composition is in the form of nasal drops.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES54774878" lang="EN" load-source="patent-office" class="description">
    <heading>FIELD OF THE INVENTION</heading> <p>The present invention relates to an aqueous liquid pharmaceutical composition comprising as a main component a quinolone carboxylic acid derivative, Gatifloxacin (chemical nomenclature: (±)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinoline carboxylic acid). Further, the present invention relates to a method for raising corneal permeability of Gatifloxacin, a method for preventing precipitation of Gatifloxacin crystals, and a method for preventing coloration of Gatifloxacin.</p>
    <heading>BACKGROUND OF THE INVENTION</heading> <p>Gatifloxacin is a new quinolone antimicrobial agent which is recognized to exhibit a strong antimicrobial activity against not only Gram-negative bacteria but also Gram-positive bacteria, anaerobes and mycoplasmas. Then, it has been proposed to apply it to ophthalmological infectious diseases such as conjunctivitis, dacryocystitis, hordeolum etc. and otorhinological infectious diseases such as otitis externa, otitis media, sinusitis etc (see JP-B 8-9597).</p>
    <p>For designing a pharmaceutical preparation in the form of eye drops containing an antimicrobial agent, an index is to raise corneal permeability of the agent to increase the amount of the agent to transfer to aqueous humor. However, in general, the agent applied to eyes can scarcely pass into inside of the eyes because of dilution with tears and the barrier function of corneas. Then, as a method of improving corneal permeability of the agent, a method using an absorption enhancer has been proposed. In addition, a method using a viscous base material has been proposed to increase the agent-retentivity at the anterior ocular segment.</p>
    <heading>OBJECTS OF THE INVENTION</heading> <p>With regard to Gatifloxacin, although its application. to ophthalmological or otorhinological infectious diseases has been proposed, there is no report about a study of an aqueous liquid pharmaceutical composition thereof for topical administration, which can be actually applied to eyes, for example, its passing into inside of eyes, stability, etc.</p>
    <p>In view of these circumstances, an object of the present invention is to permit actual application of Gatifloxacin in ophthalmological or otorhinological field, in particular, to provide an aqueous liquid pharmaceutical composition comprising as an effective component Gatifloxacin.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p>The present inventors have intensively studied to apply Gatifloxacin in ophthalmological field and, consequently, have found that this objective can be achieved by coexistence of Gatifloxacin with disodium edetate.</p>
    <p>Disodium edetate is considered to lower the calcium concentration in corneal epithelium cells and expanding intercellular spaces, thereby accelerating passing of a water-soluble medicament into inside of eyes. However, a rise in corneal permeability of a medicament depends on a concentration of disodium edetate (Journal of Pharmaceutical Science, 77: 3-14, 1988) and, normally, at present, disodium edetate should be used at a high concentration as much as 0.5% (Investigative Ophthalmology &amp; Visual Science, 66: 110-113, 1985; Experimental Eye Research, 54: 747-757, 1992; Pharmaceutical Research, 12: 1146-1150). Nevertheless, the present inventors have found that corneal permeability of Gatifloxacin can be improved at a lower concentration of disodium edetate.</p>
    <p>Further, it has been known that the solubility of Gatifloxacin depends on pH and its solubility at about physiological pH is very low. Then, in order to dissolve a sufficient amount of Gatifloxacin in an aqueous liquid pharmaceutical composition, pH of the composition should be adjusted to an acidic or alkaline range, which causes a problem such as irritation upon topical administration. However, the present inventors also have found that the solubility of Gatifloxacin at about physiological pH is improved by coexistence thereof with disodium edetate.</p>
    <p>The present invention has been completed based on these present inventors' novel findings and, according to the present invention, there is provided an aqueous liquid pharmaceutical composition which comprises Gatifloxacin or its salt and disodium edetate. In particular, the aqueous liquid pharmaceutical composition of the present invention is an aqueous solution containing Gatifloxacin or its salt and disodium edetate.</p>
    <p>Further, the present invention provides a method for raising corneal permeability of Gatifloxacin which comprises incorporating disodium edetate into eye drops containing Gatifloxacin or its salt; a method for preventing precipitation of Gatifloxacin crystals which comprises incorporating disodium edetate into an aqueous liquid preparation containing Gatifloxacin or its salt; and a method for preventing coloration of Gatifloxacin which comprises incorporating disodium edetate into an aqueous liquid preparation containing Gatifloxacin or its salt.</p>
    <p>This object as well as other objects and advantages of the present invention will become apparent to those skilled in the art from the following description.</p>
    <heading>DETAILED DESCRIPTION OF THE INVENTION</heading> <p>In the present invention, Gatifloxacin or its salt is used as the effective component. Examples of the salt of Gatifloxacin used in the present invention include those with inorganic acids such as hydrochloric acid, sulfuric acid, phosphoric acid, etc.; those with organic acids such as methanesulfonic acid, lactic acid, oxalic acid, acetic acid, etc.; or those with sodium, potassium, magnesium, calcium, aluminum, cerium, chromium, cobalt, copper, iron, zinc, platinum, silver, etc.</p>
    <p>Normally, the amount of Gatifloxacin or its salt (hereinafter sometimes simply referred to as “Gatifloxacin”) to be formulated in the aqueous liquid pharmaceutical composition of the present invention is varied according to the degree of infection of a particular subject, but normally, Gatifloxacin is formulated within the range of 0.1 to 1.0 w/v %, preferably 0.1 to 0.8 w/v %, more preferably 0.3 to 0.5 w/v %.</p>
    <p>Normally, disodium edetate is formulated in an amount of 0.001 to 0.2 w/v %, preferably 0.005 to 0.1 w/v %, more preferably 0.01 to 0.1 w/v %.</p>
    <p>Normally, the aqueous liquid pharmaceutical composition of the present invention is adjusted to pH 5 to 8, preferably pH 5.5 to 7.5, more preferably pH 6 to 7.</p>
    <p>If necessary, the aqueous liquid pharmaceutical composition of the present invention may further contain appropriate additives, for example, an isotonic agent. (e.g., sodium chloride, potassium chloride, boric acid, glycerin, propylene glycol, mannitol, sorbitol, glucoseetc.); a buffer solution (e.g., phosphate buffer solution, acetate butter solution, borate buffer solution, citrate buffer solution, glutamic acid, ε-aminocapronic acid, etc.); a preservative (e.g., benzalkonium chloride, benzethonium chloride, chlorhexidine gluconate, chlorobutanol, benzyl alcohol, sodium dehydroacetate, p-hydroxybenzoate, etc.), a thickening agent (e.g., methylcellulose, hydroxyethyl cellulose, hydroxypropyl methylcellulose, carboxymethylcellulose, sodium hyaluronate, carboxyvinyl polymer, polyvinyl alcohol, polyvinyl pyrrolidone, Macrogol (polyethylene glycol), etc.), a pH adjusting agent (e.g., hydrochloric acid, sodium hydroxide, acetic acid, phosphoric acid, etc.), and the like.</p>
    <p>The aqueous liquid pharmaceutical composition of the present invention can be produced by a per se known method. For example, it can be produced by the process described in the section of “Ophthalmic Solutions” or “Liquids and Solutions”, General Rules for Preparations, The Japanese Pharmacopoeia Thirteenth Edition.</p>
    <p>The aqueous liquid pharmaceutical composition of the present invention has antimicrobial activity and can be used for prophylaxis and therapy of blepharitis, hordeolum, dacryocystitis, conjunctivitis, tarsitis, keratitis, corneal ulcer, postoperative infection, and the like. For this purpose, the composition can be instilled in the eye about three times a day at a dosage of one drop per once. For otitis externa or otitis media, normally, the composition can be instilled in the ear twice a day at a dosage of 6 to 10 drops per once. Further, for sinusitis, normally, the composition can be sprayed and inhaled three times every other day in a week at a dosage of 2 to 4 ml per once, or can be administered in the maxillary sinus once a week at a dosage of 1 ml per once. The dosage can be increased or decreased according to the degree of a particular disease condition.</p>
    <p>The present invention will be further illustrated by the following experiments and examples, but the present invention is not limited thereto.</p>
    <p>Experiment 1</p>
    <p>Effect of disodium edetate on transfer of Gatifloxacin to aqueous humor</p>
    <p>Method</p>
    <p>According to the formulations of Table 1, eye drops of Gatifloxacin were prepared (formulations A-C). Each of the eye drops (50 μl/eye) was instilled once in the eyes of male Japanese albino rabbits (body weight: about 2 kg). At one hour after the instillation, the aqueous humor was collected and the Gatifloxacin concentration was determined by HPLC.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="5" colsep="0" rowsep="0" align="left"> <colspec colname="OFFSET" align="left" colwidth="14PT"> </colspec> <colspec colname="1" align="left" colwidth="77PT"> </colspec> <colspec colname="2" align="center" colwidth="49PT"> </colspec> <colspec colname="3" align="center" colwidth="28PT"> </colspec> <colspec colname="4" align="center" colwidth="49PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="4" morerows="0" rowsep="1" valign="top" class="description-td" colspan="5">TABLE 1</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="4" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="5"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Formulations</td>
                <td morerows="0" valign="top" class="description-td">A</td>
                <td morerows="0" valign="top" class="description-td">B</td>
                <td morerows="0" valign="top" class="description-td">C</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="4" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="5"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Gatifloxacin</td>
                <td morerows="0" valign="top" class="description-td">0.5 g</td>
                <td morerows="0" valign="top" class="description-td">0.5 g</td>
                <td morerows="0" valign="top" class="description-td">0.5 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Disodium edetate</td>
                <td morerows="0" valign="top" class="description-td">—</td>
                <td morerows="0" valign="top" class="description-td">—</td>
                <td morerows="0" valign="top" class="description-td"> 0.05 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium chloride</td>
                <td morerows="0" valign="top" class="description-td">0.9 g</td>
                <td morerows="0" valign="top" class="description-td">0.9 g</td>
                <td morerows="0" valign="top" class="description-td">0.9 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Hydrochloric acid</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium hydroxide</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sterilized purified water</td>
                <td morerows="0" valign="top" class="description-td">to total</td>
                <td morerows="0" valign="top" class="description-td">to total</td>
                <td morerows="0" valign="top" class="description-td">to total</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">100 ml</td>
                <td morerows="0" valign="top" class="description-td">100 ml</td>
                <td morerows="0" valign="top" class="description-td">100 ml</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">pH</td>
                <td morerows="0" valign="top" class="description-td">7.0</td>
                <td morerows="0" valign="top" class="description-td">6.0</td>
                <td morerows="0" valign="top" class="description-td">6.0</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="4" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="5"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>Results</p>
    <p>The concentration of Gatifloxacin in the aqueous humor at one hour after the instillation is shown in Table 2.</p>
    <p>When pH dropped, the amount of Gatifloxacin transferred to the aqueous humor decreased. For the formulation adjusted to pH 6.0 (formulation C), the amount of Gatifloxacin transferred to the aqueous humor increased by about 1.2 times and 1.5 times as much as those of the formulations A (pH 7.0) and B (pH 6.0) which were used as controls, respectively.</p>
    <p>Since the concentration of disodium edetate normally used for raising corneal permeability is 0.5 w/v %, these results show that corneal permeability of Gatifloxacin has been improved even by using disodium edetate in 1/10 amount as much as that normally used.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="OFFSET" align="left" colwidth="21PT"> </colspec> <colspec colname="1" align="center" colwidth="42PT"> </colspec> <colspec colname="2" align="center" colwidth="154PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" class="description-td" colspan="3">TABLE 2</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Gatifloxacin concentration in aqueous</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Formulations</td>
                <td morerows="0" valign="top" class="description-td">humor (μg/ml)</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">A</td>
                <td morerows="0" valign="top" class="description-td">1.61 ± 0.43</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">B</td>
                <td morerows="0" valign="top" class="description-td">1.30 ± 0.42</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">C</td>
                <td morerows="0" valign="top" class="description-td">1.93 ± 0.95</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>Experiment 2</p>
    <p>Effect of disodium edetate on precipitation of Gatifloxacin crystals</p>
    <p>Method</p>
    <p>According to the formulations of Table 3, aqueous liquid preparations of Gatifloxacin were prepared (formulations B-D). Each solution was filled in 5 ml glass ampoules. The ampoules were subjected to freezing at −30° C. (overnight) and then thawing at room temperature repeatedly to observe precipitation of Gatifloxacin crystals.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="5" colsep="0" rowsep="0" align="left"> <colspec colname="OFFSET" align="left" colwidth="14PT"> </colspec> <colspec colname="1" align="left" colwidth="77PT"> </colspec> <colspec colname="2" align="center" colwidth="49PT"> </colspec> <colspec colname="3" align="center" colwidth="28PT"> </colspec> <colspec colname="4" align="center" colwidth="49PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="4" morerows="0" rowsep="1" valign="top" class="description-td" colspan="5">TABLE 3</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="4" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="5"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Formulations</td>
                <td morerows="0" valign="top" class="description-td">B</td>
                <td morerows="0" valign="top" class="description-td">C</td>
                <td morerows="0" valign="top" class="description-td">D</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="4" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="5"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Gatifloxacin</td>
                <td morerows="0" valign="top" class="description-td">0.5 g</td>
                <td morerows="0" valign="top" class="description-td">0.5 g</td>
                <td morerows="0" valign="top" class="description-td">0.5 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Disodium edetate</td>
                <td morerows="0" valign="top" class="description-td">—</td>
                <td morerows="0" valign="top" class="description-td"> 0.05 g</td>
                <td morerows="0" valign="top" class="description-td">0.1 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium chloride</td>
                <td morerows="0" valign="top" class="description-td">0.9 g</td>
                <td morerows="0" valign="top" class="description-td">0.9 g</td>
                <td morerows="0" valign="top" class="description-td">0.9 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Hydrochloric acid</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium hydroxide</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sterilized purified water</td>
                <td morerows="0" valign="top" class="description-td">to total</td>
                <td morerows="0" valign="top" class="description-td">to total</td>
                <td morerows="0" valign="top" class="description-td">to total</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">100 ml</td>
                <td morerows="0" valign="top" class="description-td">100 ml</td>
                <td morerows="0" valign="top" class="description-td">100 ml</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">pH</td>
                <td morerows="0" valign="top" class="description-td">6.0</td>
                <td morerows="0" valign="top" class="description-td">6.0</td>
                <td morerows="0" valign="top" class="description-td">6.0</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="4" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="5"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>Results</p>
    <p>In the formulation in which disodium edetate was not formulated (formulation B), crystals were precipitated when freezing and thawing were repeated twice to three times. On the other hand, when disodium edetate was formulated (formulations C and D), no precipitation of crystals was recognized even when freezing and thawing were repeated ten times.</p>
    <p>These results show that precipitation of Gatifloxacin crystals under storage conditions at a low temperature is prevented by formulating disodium edetate in an aqueous liquid preparation of Gatifloxacin.</p>
    <p>Experiment 3</p>
    <p>Effect of disodium edetate on preventing coloration of Gatifloxacin</p>
    <p>Method</p>
    <p>Sodium chloride (0.86 g) and 0.1 mol/liter hydrochloric acid (5.2 ml) were added to sterilized purified water (80 ml) in a stainless steel (SUS316) beaker of 8 cm diameter and the mixture was stirred. Then, Gatifloxacin (0.32 g) and disodium edetate (at a final concentration of 0%, 0.001%, 0.005%, 0.01% or 0.05%) were added thereto and dissolved therein. The solution was adjusted to pH 6.5 with 0.1 mol/liter sodium hydroxide and the total volume was made up to 100 ml to obtain an aqueous liquid preparation of Gatifloxacin. A color difference between the aqueous liquid preparation and sterilized purified water was determined with a differential calorimeter (Chroma meter CT-210C manufactured by Minolta, light source Lab table system). As a control, an aqueous liquid preparation of Gatifloxacin prepared in a glass beaker was used.</p>
    <p>Results</p>
    <p>The color difference determined is shown in Table 4.</p>
    <p>The aqueous liquid preparation prepared in the glass beaker and used as the control had the color difference of 1.9 to 2.0 and a pale yellow color. On the other hand, the aqueous liquid preparation prepared in the stainless steel beaker had the color difference of 3.17 in case that disodium edetate was not added and 2.42 in case that 0.01% of disodium edetate was added. They had a light yellow color and a pale yellow color, respectively. Thus, they were discolored by formulating disodium edetate.</p>
    <p>In view of these results, it is considered that Gatifloxacin is colored by the metal ion dissolved in the preparation from the stainless steel beaker. Further, these results show that addition of disodium edetate can prevent coloration of Gatifloxacin.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="1" align="center" colwidth="91PT"> </colspec> <colspec colname="2" align="center" colwidth="119PT"> </colspec> <colspec colname="3" align="left" colwidth="7PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td namest="1" nameend="3" morerows="0" rowsep="1" valign="top" class="description-td" colspan="3">TABLE 4</td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td namest="1" nameend="3" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td">Concentration of</td>
                <td morerows="0" valign="top" class="description-td">Color Difference</td>
                <td morerows="0" valign="top" class="description-td"> </td>
              </tr> </tbody> </tgroup> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="1" align="center" colwidth="91PT"> </colspec> <colspec colname="2" align="center" colwidth="70PT"> </colspec> <colspec colname="3" align="center" colwidth="56PT"> </colspec> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td">disodium edetate (%)</td>
                <td morerows="0" valign="top" class="description-td">Stainless Steel Beaker</td>
                <td morerows="0" valign="top" class="description-td">Glass Beaker</td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="3" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="1" align="char" char="." colwidth="91PT"> </colspec> <colspec colname="2" align="center" colwidth="70PT"> </colspec> <colspec colname="3" align="center" colwidth="56PT"> </colspec> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td">0</td>
                <td morerows="0" valign="top" class="description-td">3.17</td>
                <td morerows="0" valign="top" class="description-td">1.90</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td">0.001</td>
                <td morerows="0" valign="top" class="description-td">3.08</td>
                <td morerows="0" valign="top" class="description-td">1.93</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td">0.005</td>
                <td morerows="0" valign="top" class="description-td">3.05</td>
                <td morerows="0" valign="top" class="description-td">2.02</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td">0.01</td>
                <td morerows="0" valign="top" class="description-td">2.42</td>
                <td morerows="0" valign="top" class="description-td">1.94</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td">0.05</td>
                <td morerows="0" valign="top" class="description-td">2.19</td>
                <td morerows="0" valign="top" class="description-td">1.93</td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="3" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <heading>EXAMPLE 1</heading> <p>According to a conventional method, an aqueous solution for eye drops, ear drops and nasal drops having the following formulation was prepared.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="OFFSET" align="left" colwidth="35PT"> </colspec> <colspec colname="1" align="left" colwidth="77PT"> </colspec> <colspec colname="2" align="center" colwidth="105PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Ingredients</td>
                <td morerows="0" valign="top" class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Gatifloxacin</td>
                <td morerows="0" valign="top" class="description-td">0.5 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Disodium edetate</td>
                <td morerows="0" valign="top" class="description-td">0.1 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium chloride</td>
                <td morerows="0" valign="top" class="description-td">0.9 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Hydrochloric acid</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium hydroxide</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sterilized purified water</td>
                <td morerows="0" valign="top" class="description-td">up to 100 ml</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">pH</td>
                <td morerows="0" valign="top" class="description-td">7.0</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <heading>EXAMPLE 2</heading> <p>According to a conventional method, an aqueous solution for eye drops, ear drops and nasal drops having the following formulation was prepared.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="OFFSET" align="left" colwidth="35PT"> </colspec> <colspec colname="1" align="left" colwidth="77PT"> </colspec> <colspec colname="2" align="center" colwidth="105PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Ingredients</td>
                <td morerows="0" valign="top" class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Gatifloxacin</td>
                <td morerows="0" valign="top" class="description-td">0.5 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Disodium edetate</td>
                <td morerows="0" valign="top" class="description-td">0.05 g </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium chloride</td>
                <td morerows="0" valign="top" class="description-td">0.9 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Hydrochloric acid</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium hydroxide</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">sterilized purified water</td>
                <td morerows="0" valign="top" class="description-td">up to 100 ml</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">pH</td>
                <td morerows="0" valign="top" class="description-td">7.0</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <heading>EXAMPLE 3</heading> <p>According to a conventional method, an aqueous solution for eye drops, ear drops and nasal drops having the following formulation was prepared.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="OFFSET" align="left" colwidth="28PT"> </colspec> <colspec colname="1" align="left" colwidth="91PT"> </colspec> <colspec colname="2" align="center" colwidth="98PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Ingredients</td>
                <td morerows="0" valign="top" class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Gatifloxacin</td>
                <td morerows="0" valign="top" class="description-td">0.5 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Disodium edetate</td>
                <td morerows="0" valign="top" class="description-td">0.1 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium dihydrogen phosphate</td>
                <td morerows="0" valign="top" class="description-td">0.1 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium chloride</td>
                <td morerows="0" valign="top" class="description-td">0.9 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Hydrochloric acid</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium hydroxide</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sterilized purified water</td>
                <td morerows="0" valign="top" class="description-td">up to 100 ml</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">pH</td>
                <td morerows="0" valign="top" class="description-td">7.0</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <heading>EXAMPLE 4</heading> <p>According to a conventional method, an aqueous solution for eye drops, ear drops and nasal drops having the following formulation was prepared.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="OFFSET" align="left" colwidth="35PT"> </colspec> <colspec colname="1" align="left" colwidth="77PT"> </colspec> <colspec colname="2" align="center" colwidth="105PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Ingredients</td>
                <td morerows="0" valign="top" class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Gatifloxacin</td>
                <td morerows="0" valign="top" class="description-td">0.3 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Disodium edetate</td>
                <td morerows="0" valign="top" class="description-td">0.05 g </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium chloride</td>
                <td morerows="0" valign="top" class="description-td">0.9 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Hydrochloric acid</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium hydroxide</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sterilized purified water</td>
                <td morerows="0" valign="top" class="description-td">up to 100 ml</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">pH</td>
                <td morerows="0" valign="top" class="description-td">6.0</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <heading>EXAMPLE 5</heading> <p>According to a conventional method, an aqueous solution for eye drops, ear drops and nasal drops having the following formulation was prepared.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="OFFSET" align="left" colwidth="35PT"> </colspec> <colspec colname="1" align="left" colwidth="77PT"> </colspec> <colspec colname="2" align="center" colwidth="105PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Ingredients</td>
                <td morerows="0" valign="top" class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Gatifloxacin</td>
                <td morerows="0" valign="top" class="description-td">0.5 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium edetate</td>
                <td morerows="0" valign="top" class="description-td">0.01 g </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Glycerin</td>
                <td morerows="0" valign="top" class="description-td">2.6 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Benzalkonium chloride</td>
                <td morerows="0" valign="top" class="description-td">0.005 g </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Hydrochloric acid</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium hydroxide</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sterilized purified water</td>
                <td morerows="0" valign="top" class="description-td">up to 100 ml</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">pH</td>
                <td morerows="0" valign="top" class="description-td">7.5</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <heading>EXAMPLE 6</heading> <p>According to a conventional method, an aqueous solution for eye drops, ear drops and nasal drops having the following formulation was prepared.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="OFFSET" align="left" colwidth="35PT"> </colspec> <colspec colname="1" align="left" colwidth="77PT"> </colspec> <colspec colname="2" align="center" colwidth="105PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Ingredients</td>
                <td morerows="0" valign="top" class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Gatifloxacin</td>
                <td morerows="0" valign="top" class="description-td">0.5 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium edetate</td>
                <td morerows="0" valign="top" class="description-td">0.05 g </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium chloride</td>
                <td morerows="0" valign="top" class="description-td">0.9 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Hydrochloric acid</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium hydroxide</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sterilized purified water</td>
                <td morerows="0" valign="top" class="description-td">up to 100 ml</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">pH</td>
                <td morerows="0" valign="top" class="description-td">5.5</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <heading>EXAMPLE 7</heading> <p>According to a conventional method, an aqueous solution for eye drops, ear drops and nasal drops having the following formulation was prepared.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="OFFSET" align="left" colwidth="28PT"> </colspec> <colspec colname="1" align="left" colwidth="98PT"> </colspec> <colspec colname="2" align="center" colwidth="91PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Ingredients</td>
                <td morerows="0" valign="top" class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Gatifloxacin</td>
                <td morerows="0" valign="top" class="description-td">0.3 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Disodium edetate</td>
                <td morerows="0" valign="top" class="description-td">0.05 g </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium chloride</td>
                <td morerows="0" valign="top" class="description-td">0.9 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Hydroxypropylmethyl cellulose</td>
                <td morerows="0" valign="top" class="description-td">0.1 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Methyl p-hydroxybenzoate</td>
                <td morerows="0" valign="top" class="description-td">0.026 g </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Propyl p-hydroxybenzoate</td>
                <td morerows="0" valign="top" class="description-td">0.014 g </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Hydrochloric acid</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium hydroxide</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sterilized purified water</td>
                <td morerows="0" valign="top" class="description-td">up to 100 ml</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">pH</td>
                <td morerows="0" valign="top" class="description-td">6.0</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <heading>EXAMPLE 8</heading> <p>According to a conventional method, an aqueous solution for eye drops, ear drops and nasal drops having the following formulation was prepared.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="OFFSET" align="left" colwidth="35PT"> </colspec> <colspec colname="1" align="left" colwidth="77PT"> </colspec> <colspec colname="2" align="center" colwidth="105PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Ingredients</td>
                <td morerows="0" valign="top" class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Gatifloxacin</td>
                <td morerows="0" valign="top" class="description-td"> 0.5 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Disodium edetate</td>
                <td morerows="0" valign="top" class="description-td">0.01 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium chloride</td>
                <td morerows="0" valign="top" class="description-td">0.83 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Benzalkonium chloride</td>
                <td morerows="0" valign="top" class="description-td">0.005 g </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Hydrochloric acid</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium hydroxide</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sterilized purified water</td>
                <td morerows="0" valign="top" class="description-td">up to 100 ml</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">pH</td>
                <td morerows="0" valign="top" class="description-td">5.5</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <heading>EXAMPLE 9</heading> <p>According to a conventional method, an aqueous solution for eye drops, ear drops and nasal drops having the following formulation was prepared.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup cols="3" colsep="0" rowsep="0" align="left"> <colspec colname="OFFSET" align="left" colwidth="28PT"> </colspec> <colspec colname="1" align="left" colwidth="77PT"> </colspec> <colspec colname="2" align="center" colwidth="112PT"> </colspec> <thead valign="bottom"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Ingredients</td>
                <td morerows="0" valign="top" class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Gatifloxacin</td>
                <td morerows="0" valign="top" class="description-td">0.3 g </td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Disodium edetate</td>
                <td morerows="0" valign="top" class="description-td">0.01 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium chloride</td>
                <td morerows="0" valign="top" class="description-td">0.86 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Benzalkonium chloride</td>
                <td morerows="0" valign="top" class="description-td"> 0.005 g</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Hydrochloric acid</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sodium hydroxide</td>
                <td morerows="0" valign="top" class="description-td">q.s.</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">Sterilized purified water</td>
                <td morerows="0" valign="top" class="description-td">up to 100 ml</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td morerows="0" valign="top" class="description-td">pH</td>
                <td morerows="0" valign="top" class="description-td">6.0</td>
              </tr> <tr class="description-tr"> <td morerows="0" valign="top" class="description-td"> </td>
                <td namest="OFFSET" nameend="2" morerows="0" rowsep="1" valign="top" align="center" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>As shown in Experiment 1, according to the eye drops of the present invention, corneal permeability of the effective component, Gatifloxacin, can be improved even by using disodium edetate in 1/10 amount as much as that normally used. Further, as shown in Experiment 2, the aqueous liquid preparation of the present invention can. prevent precipitation of Gatifloxacin crystals under storage conditions as a low temperature. Furthermore, as shown in Experiment 3, coloration of Gatifloxacin by a metal ion can be prevented. Thus, the aqueous liquid preparation of the present invention is very useful.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4528287">US4528287</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 17, 1984</td><td class="patent-data-table-td patent-date-value">Jul 9, 1985</td><td class="patent-data-table-td ">Hokuriku Pharmaceutical Co., Ltd.</td><td class="patent-data-table-td ">6-Fluoro-1, 4-dihydro-4-oxo-7-substituted piperazinylquinoline-3-carboxylic acids and the method for preparing the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4780465">US4780465</a></td><td class="patent-data-table-td patent-date-value">May 20, 1987</td><td class="patent-data-table-td patent-date-value">Oct 25, 1988</td><td class="patent-data-table-td ">Hokuriku Pharmaceutical Co., Ltd.</td><td class="patent-data-table-td ">Aqueous solution containing a quinolone carboxylic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4980470">US4980470</a></td><td class="patent-data-table-td patent-date-value">Jan 16, 1987</td><td class="patent-data-table-td patent-date-value">Dec 25, 1990</td><td class="patent-data-table-td ">Kyorin Pharmaceutical Co., Ltd.</td><td class="patent-data-table-td ">Gatifloxacin antibiotic claimed</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5043450">US5043450</a></td><td class="patent-data-table-td patent-date-value">Oct 22, 1990</td><td class="patent-data-table-td patent-date-value">Aug 27, 1991</td><td class="patent-data-table-td ">Kyorin Pharmaceutical Co., Ltd.</td><td class="patent-data-table-td ">8-alkoxyquinolonecarboxylic acid and salts thereof</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Grass George M., et al., "<a href='http://scholar.google.com/scholar?q="Effects+of+Calcium+Chelating+Agents+on+Corneal+Permeability"'>Effects of Calcium Chelating Agents on Corneal Permeability</a>", Investigative Ophthalmology &amp; Visual Science/Jan. 1985, vol. 26, pp. 110-113.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Grass George M., et al., "<a href='http://scholar.google.com/scholar?q="Mechanisms+of+Corneal+Drug+Penetration+1%3A+In+Vivo+and+In+Vitro+Kinetics"'>Mechanisms of Corneal Drug Penetration 1: In Vivo and In Vitro Kinetics</a>", Journal of Pharmaceutical Sciences, Jan. 1988, vol. 77, No. 1, pp. 3-14.</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Kubo Shuta et al., "<a href='http://scholar.google.com/scholar?q="Enhanced+Chemiluminescence+Response+of+Polymorphonuclear+Leukocytes+by+New+Quinolone+Antimicrobials"'>Enhanced Chemiluminescence Response of Polymorphonuclear Leukocytes by New Quinolone Antimicrobials</a>", Chemotherapy, 1994, vol. 40, No. 5, pp. 333-336.</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Podder, Samir K., et al. "<a href='http://scholar.google.com/scholar?q="Improving+the+Safety+of+Topically+Applied+Timolol+in+the+Pigmented+Rabbit+Through+Manipulation+of+Formulation+Composition"'>Improving the Safety of Topically Applied Timolol in the Pigmented Rabbit Through Manipulation of Formulation Composition</a>", Exp. Eye Res. (1992), 54, pp. 747-757.</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Sasaki, Hitoshi et al., "<a href='http://scholar.google.com/scholar?q="Different+Effects+of+Absorption+Promoters+on+Corneal+and+Conjunctival+Penetration+of+Ophthalmic+Beta-Blockers"'>Different Effects of Absorption Promoters on Corneal and Conjunctival Penetration of Ophthalmic Beta-Blockers</a>", Pharmaceutical Research, 1995, vol. 12, No. 8, pp. 1146-1150.</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Tanaka, Masatoshi et al., "<a href='http://scholar.google.com/scholar?q="Emergence+of+In+Vitro+Resistance+to+Fluoroquinolones+in+Neisseria+gonorrhoeae+Isolated+in+Japan"'>Emergence of In Vitro Resistance to Fluoroquinolones in Neisseria gonorrhoeae Isolated in Japan</a>", Antimicrobial Agents and Chemotherapy, 1995, vol. 39, No. 10, pp. 2367-2370.</td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6582609">US6582609</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 30, 2001</td><td class="patent-data-table-td patent-date-value">Jun 24, 2003</td><td class="patent-data-table-td ">Kyorin Pharmaceutical Co., Ltd.</td><td class="patent-data-table-td ">Recycling 1-cyclopropyl-7-(3-methyl-1-piperazinyl)-6-fluoro-8-methoxy-1,4-dihydro-4 -oxo-3-quinolinecarboxylic acid, sulfate (gatifloxacin sulfate)</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7741339">US7741339</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2007</td><td class="patent-data-table-td patent-date-value">Jun 22, 2010</td><td class="patent-data-table-td ">Affinium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Fab I inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7790709">US7790709</a></td><td class="patent-data-table-td patent-date-value">Dec 5, 2003</td><td class="patent-data-table-td patent-date-value">Sep 7, 2010</td><td class="patent-data-table-td ">Affinium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Heterocyclic compounds, methods of making them and their use in therapy</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7790716">US7790716</a></td><td class="patent-data-table-td patent-date-value">Mar 12, 2009</td><td class="patent-data-table-td patent-date-value">Sep 7, 2010</td><td class="patent-data-table-td ">Affinium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">fatty acid biosynthesis inhibitors such as E)-3-(6-aminopyridin-3-yl)-N-methyl-N-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)acrylamide, used fro the treatment of bacterial infections; antibiotics</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7838532">US7838532</a></td><td class="patent-data-table-td patent-date-value">May 18, 2006</td><td class="patent-data-table-td patent-date-value">Nov 23, 2010</td><td class="patent-data-table-td ">Mpex Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">aqueous solution of levofloxacin or ofloxacin and a divalent or trivalent cation such as magnesium chloride, wherein the solution is suitable for inhalation into a lung; treatment of respiratory tract and pulmonary infections</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7879872">US7879872</a></td><td class="patent-data-table-td patent-date-value">Sep 19, 2005</td><td class="patent-data-table-td patent-date-value">Feb 1, 2011</td><td class="patent-data-table-td ">Affinium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Compositions comprising multiple bioactive agents, and methods of using the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8153652">US8153652</a></td><td class="patent-data-table-td patent-date-value">Apr 12, 2010</td><td class="patent-data-table-td patent-date-value">Apr 10, 2012</td><td class="patent-data-table-td ">Affinium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Fab I inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8173646">US8173646</a></td><td class="patent-data-table-td patent-date-value">Jul 6, 2010</td><td class="patent-data-table-td patent-date-value">May 8, 2012</td><td class="patent-data-table-td ">Affinium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">FAB I inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8263613">US8263613</a></td><td class="patent-data-table-td patent-date-value">Feb 15, 2008</td><td class="patent-data-table-td patent-date-value">Sep 11, 2012</td><td class="patent-data-table-td ">Affinium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Salts, prodrugs and polymorphs of fab I inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8318720">US8318720</a></td><td class="patent-data-table-td patent-date-value">Jul 19, 2007</td><td class="patent-data-table-td patent-date-value">Nov 27, 2012</td><td class="patent-data-table-td ">Affinium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Acrylamide derivatives as Fab I inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8450307">US8450307</a></td><td class="patent-data-table-td patent-date-value">Jun 6, 2005</td><td class="patent-data-table-td patent-date-value">May 28, 2013</td><td class="patent-data-table-td ">Affinium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Therapeutic agents, and methods of making and using the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2687533A2?cl=en">EP2687533A2</a></td><td class="patent-data-table-td patent-date-value">Jul 19, 2007</td><td class="patent-data-table-td patent-date-value">Jan 22, 2014</td><td class="patent-data-table-td ">Affinium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Acrylamide derivatives as FAB I inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2004052890A1?cl=en">WO2004052890A1</a></td><td class="patent-data-table-td patent-date-value">Dec 5, 2003</td><td class="patent-data-table-td patent-date-value">Jun 24, 2004</td><td class="patent-data-table-td ">Affinium Pharm Inc</td><td class="patent-data-table-td ">Heterocyclic compounds, methods of making them and their use in therapy</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2008009122A1?cl=en">WO2008009122A1</a></td><td class="patent-data-table-td patent-date-value">Jul 19, 2007</td><td class="patent-data-table-td patent-date-value">Jan 24, 2008</td><td class="patent-data-table-td ">Affinium Pharm Inc</td><td class="patent-data-table-td ">Acrylamide derivatives as fab i inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2009123098A1?cl=en">WO2009123098A1</a></td><td class="patent-data-table-td patent-date-value">Mar 30, 2009</td><td class="patent-data-table-td patent-date-value">Oct 8, 2009</td><td class="patent-data-table-td ">Kyorin Pharmaceutical Co., Ltd.</td><td class="patent-data-table-td ">Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2009123099A1?cl=en">WO2009123099A1</a></td><td class="patent-data-table-td patent-date-value">Mar 30, 2009</td><td class="patent-data-table-td patent-date-value">Oct 8, 2009</td><td class="patent-data-table-td ">Kyorin Pharmaceutical Co., Ltd.</td><td class="patent-data-table-td ">Aqueous liquid containing gatifloxacin</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S434000">424/434</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S427000">424/427</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S400000">424/400</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S437000">424/437</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S078040">424/78.04</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S422000">424/422</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0215560000">C07D215/56</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031496000">A61K31/496</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047180000">A61K47/18</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0009000000">A61K9/00</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C07D215/56">C07D215/56</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K47/183">A61K47/183</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K9/0043">A61K9/0043</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K9/0048">A61K9/0048</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=8ENYBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/496">A61K31/496</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61K9/00M14</span>, <span class="nested-value">A61K31/496</span>, <span class="nested-value">A61K47/18B</span>, <span class="nested-value">A61K9/00M16</span>, <span class="nested-value">C07D215/56</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Mar 29, 2013</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">12</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 15, 2012</td><td class="patent-data-table-td ">CC</td><td class="patent-data-table-td ">Certificate of correction</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 10, 2012</td><td class="patent-data-table-td ">CC</td><td class="patent-data-table-td ">Certificate of correction</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 25, 2011</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIMS 1-3 AND 8-11 ARE CANCELLED. CLAIM 6 IS DETERMINED TO BE PATENTABLE AS AMENDED. NEW CLAIMS 12-16 ARE ADDED AND DETERMINED TO BE PATENTABLE. CLAIMS 4, 5 AND 7 WERE NOT REEXAMINED.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 3, 2011</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20110225</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 30, 2009</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jul 13, 2005</td><td class="patent-data-table-td ">REMI</td><td class="patent-data-table-td ">Maintenance fee reminder mailed</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Jun 3, 2005</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 21, 2000</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">KYORIN PHARMACEUTICAL CO., LTD., JAPAN</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">SENJU PHARMACEUTICAL CO., LTD., JAPAN</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YASUEDA, SHINICHI;INADA, KATSUHIRO;REEL/FRAME:010798/0892</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20000316</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">KYORIN PHARMACEUTICAL CO., LTD. 5, KANDASURUGADAI</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">SENJU PHARMACEUTICAL CO., LTD. 5-8, HIRANOMACHI 2-</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U0jGinYzcdufqWeuBBi1rdR-UsHQA\u0026id=8ENYBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U3FXMbhuXFt8FX0B4byBYdrhmGuiw\u0026id=8ENYBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U29e8roP0ArY3Wl8ko6vz9kp7EzaQ","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Gatifloxacin_or_its_salt_and_disodium_ED.pdf?id=8ENYBAABERAJ\u0026output=pdf\u0026sig=ACfU3U2zA4kFdY1ew-SJWnQz0xP0jkZRfw"},"sample_url":"http://www.google.com/patents/reader?id=8ENYBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>